Winton Group LTD Allakos Inc. Transaction History

Winton Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$85.37 - $114.1 $344,638 - $460,621	-4,037 Closed	0 $0
Q1 2021 Jul 21, 2021	SELL	$109.73 - $153.66 $451,429 - $632,157	-4,114 Reduced 50.47%	4,037 $463,000
Q4 2020 Feb 12, 2021	SELL	$79.58 - $152.45 $1.73 Million - $3.3 Million	-21,679 Reduced 72.68%	8,151 $1.14 Million
Q3 2020 Oct 30, 2020	SELL	$66.43 - $90.99 $738,834 - $1.01 Million	-11,122 Reduced 27.16%	29,830 $2.43 Million
Q2 2020 Aug 05, 2020	BUY	$44.04 - $80.69 $760,218 - $1.39 Million	17,262 Added 72.87%	40,952 $2.94 Million
Q1 2020 May 11, 2020	SELL	$44.49 - $93.39 $61,974 - $130,092	-1,393 Reduced 5.55%	23,690 $1.05 Million
Q4 2019 Feb 13, 2020	BUY	$66.49 - $137.73 $1.07 Million - $2.21 Million	16,030 Added 177.07%	25,083 $2.39 Million
Q3 2019 Nov 08, 2019	BUY	$31.0 - $89.73 $280,643 - $812,325	9,053 New	9,053 $712,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $21.2M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.